VISTOGARD (Wellstat Therapeutics Corporation)
Welcome to the PulseAid listing for the VISTOGARD drug offered from Wellstat Therapeutics Corporation. This Pyrimidine Analog [EPC],Pyrimidines [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Wellstat Therapeutics Corporation |
| NON-PROPRIETARY NAME: | uridine triacetate |
| SUBSTANCE NAME: | URIDINE TRIACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Pyrimidine Analog [EPC],Pyrimidines [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | GRANULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-03-01 |
| END MARKETING DATE: | 0000-00-00 |
VISTOGARD HUMAN PRESCRIPTION DRUG Details:
| Item Description | VISTOGARD from Wellstat Therapeutics Corporation |
| LABELER NAME: | Wellstat Therapeutics Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 951(mg/g) |
| START MARKETING DATE: | 2016-03-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69468-151_9420a0b5-51f8-45c5-9070-26b70fabaa6f |
| PRODUCT NDC: | 69468-151 |
| APPLICATION NUMBER: | NDA208159 |
Other URIDINE TRIACETATE Pharmaceutical Manufacturers / Labelers:
